MORE THAN 10 YEARS OF SUCCESSFUL TRACK RECORD

PARTNER WITH US
PRODUCED MORE THAN
150
Cell/Viral Banks
PRODUCED MORE THAN
120
DSs/APIs
PRODUCED MORE THAN
14
DPs for Clinical Trials
DEVELOPED MORE THAN
200
Specific methods
QUALIFIED MORE THAN
500
Methods
RUNNING MORE THAN
150
Stability programs

OUR GLOBAL NETWORK

Kenya
Egypt
Uganda
Argentina
Chile
Brazil
Colombia
Canada
New Zealand
Australia
Malaysia
Bangladesh
India
Saudi Arabia
Greece
Serbia
Croatia
Slovakia
Hungary
Finland
Belgium
Netherlands
China
South Korea
Israel
Latvia
Turkey
UK
Spain
Portugal
Norway
Sweden
Czech Republic
Poland
Italy
Austria
Slovenia
Denmark
Germany
USA
Japan
France
Kenya
Egypt
Uganda
Argentina
Chile
Brazil
Colombia
Canada
New Zealand
Australia
Malaysia
Bangladesh
India
Saudi Arabia
Greece
Serbia
Croatia
Slovakia
Hungary
Finland
Belgium
Netherlands
China
South Korea
Israel
Latvia
Turkey
UK
Spain
Portugal
Norway
Sweden
Czech Republic
Poland
Italy
Austria
Slovenia
Denmark
Germany
USA
Japan
France
Kenya
Egypt
Uganda
Argentina
Chile
Brazil
Colombia
Canada
New Zealand
Australia
Malaysia
Bangladesh
India
Saudi Arabia
Greece
Serbia
Croatia
Slovakia
Hungary
Finland
Belgium
Netherlands
China
South Korea
Israel
Latvia
Turkey
UK
Spain
Portugal
Norway
Sweden
Czech Republic
Poland
Italy
Austria
Slovenia
Denmark
Germany
USA
Japan
France

WHY PARTNER
WITH US?

CONNECT WITH AN EXPERT
Fast  turnaround time

We prioritize efficiency to ensure your projects are completed on time, every time.

CLEAR & DIRECT COMMUNICATION

Our team keeps you informed at every stage with open and straightforward communication.

PRECISE TIMELINE COORDINATION

We align every step of the process to meet your deadlines with accuracy and reliability.

COST EFFECTIVE SOLUTION

Our services are designed to deliver maximum value without compromising on quality.

SCALABILITY & EXPERTISE IN GMP PRODUCTION

From small batches to large-scale manufacturing, we offer GMP-compliant solutions tailored to your needs.

CONNECT WITH AN EXPERT

CONTRACT RESEARCH & MANUFACTURING PARTNER

PRODUCT SELECTION

Development of manufacturing process & analytical methods

Small scale production 
(In-Vitro, Pre-clinical, Animal studies)

Formulation studies

Scale up manufacturing 
(Pre-clinical / Animal studies)

Manufacturing of Clinical Trial Material

Stability studies

Routine / Commercial production

CERTIFICATES

our certificates

JUST RELEASED

JAFRAL Participates in AMR Conference 2026 in Basel

The conference brought together innovators, researchers, industry leaders and policymakers with a shared mission: accelerating the development of novel solutions that can address the growing AMR crisis.

As Europe’s largest provider of high‑quality bacteriophage products for research, preclinical, and clinical applications, JAFRAL contributed to the discussion by highlighting the critical role of phage‑based therapeutics in the future AMR landscape. Our team presented insights on scalable phage manufacturing, quality control, and regulatory readiness—key aspects required to bring phage therapies closer to clinical and commercial use.

During the event, we also engaged in meaningful conversations with partners, biotech companies, and AMR-focused organizations about the potential of bacteriophages as a complementary or alternative approach to traditional antibiotics. With antibiotic resistance rising worldwide, bacteriophage therapy is increasingly recognized as a promising tool that can provide targeted, effective, and safe treatment against difficult-to-treat bacterial infections.

JAFRAL is proud to be part of the global AMR innovation ecosystem and remains committed to advancing bacteriophage manufacturing excellence. Our participation in the AMR Conference reflects our dedication to supporting cutting‑edge therapeutic development and contributing to solutions that can make a real impact on public health.

READ MORE